|
Charles E. Hart, Ph.D. joined BioMimetic in January 2004 as Chief Scientific Officer and Vice President. Prior to joining BioMimetic, he spent 21 years at ZymoGenetics, Inc., a biotechnology company focused on therapeutic proteins, where he held a variety of positions, including Senior Director of Corporate Communications and Investor Relations, Senior Director of Business Development, and Director of Protein Biochemistry. He is the author of over 50 scientific publications and holds 20 US patents, the majority of which are related to PDGF. Dr. Hart received his Ph.D. from the University of Washington, his M.S. from Oregon State University and his B.S. from the University of California at Davis. He currently holds the position of Affiliate Assistant Research Professor in the Department of Pathology at the University of Washington. | 